Clinical Trial Update: The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer [Phase 3]

View source ↗

Summary

This entry reports the results of a Phase 3 study evaluating toripalimab plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Recurrent or Metastatic NPC | Phase 3 | Status: COMPLETED | Results posted: 2022-04-18